LifePatent’s LPX line of products have officially been introduced to the general public through the largest trade show exhibiting organic and natural health and wellness products, The Natural Products Expo West.
As per a recent press release, the show is expected to run from March 3 up until March 7, where LifePatent’s Sleep Capsules, Revive Capsules and their respective starter packs will be showcased. According to the Chief Knowledge Officer of LifePatent, Annie Rouse, their use of the LPX Technology makes this cannabinoid line most advanced. Additionally, she said:
“For those seeking all of the benefits and results of CBD without the concerns of THC, this product checks all of the boxes.”
LifePatent’s Co-Founder and Chief Innovations Officer, Keith Butler also commented on this endeavor; highlighting the technology behind this line. He said:
“As we continue to innovate, the creativity behind our products is always supported by science and technology.”
Finally comes the Co-Founder and Chief Operating Officer, Phil Vail, who trusts that the,
“LPX enhanced product line raises the bar significantly […] Whether it’s our quality, consistency, purity or innovation, LifePatent products define the industry standard.”
Also referred to as the LifePatent Sleep, this respective hemp supplement is said to contain 15mg of full spectrum cannabinoids per capsule. It is said to contain a rich source of essential omegas (3,6, and 9). For a 30-count bottle, consumers can anticipate investing roughly $64.95.
What makes LPX Revive different from that of Sleep is the type of CBD used. In particular, the former includes 15mg of broad-spectrum cannabinoids, whereas the latter contains full spectrum. As for its prices, a 30-count capsules bottle costs roughly $69.95.
While the prices appear to be on a higher level, the key feature that sets LifePatent apart from the rest is their LPX technology. Based on the claims made, LPX delivers bioavailability to the hemp-CBD marketplace.
Other facets that sets this brand apart from the rest includes their emphasis placed on compliant quality control standards in their production process, third-party lab testing and diversity in expertise (i.e. researchers with medical and pharmacological backgrounds).